During your preliminary consultation, ask your radiologist, surgeon or oncologist if MammaPrint can help you make more informed choices about your treatment options. The discussion about MammaPrint should take place after your mammogram or coinciding with your initial diagnosis of early stage breast cancer. 

The decision to request MammaPrint must be made prior to surgery, allowing for the coordination of tissue sampling and submission for testing. Once you and your doctor have chosen to order the MammaPrint test, your doctor will arrange to obtain a small tissue sample of your tumor during your core needle biopsy procedure or surgery. MammaPrint testing does not require an additional procedure.
Agendia performs MammaPrint testing at its state-of-the-art CLIA (Clinical Laboratory Improvement Act) certified and CAP (College of American Pathology) registered and compliant genomics laboratories in Huntington Beach, California and Amsterdam, The Netherlands.
Agendia understands the urgency of the test result and its impact on treatment decisions. All tests are performed with quick turnaround while maintaining the strictest quality and control measures. Test results are delivered to your doctor within 7-10 days from the date of sample submission.
Please contact
Agendia will be pleased to provide your entire breast cancer medical team with more information regarding MammaPrint. Please contact 